top of page

Revision Anti-Reflux Surgery

Screenshot 2025-08-08 at 11.57.22.png

Revisional Anti-Reflux Surgery - Practice Guidelines

Definition

 

  • Elective revisional surgery to correct symptoms after previous fundoplication or LINX procedures (excludes acute complications of primary procedure)

Classification

Classification of previous Anti-Reflux surgery failure requiring revisional surgery

 

Type I        

In-situ fundoplication disruption

Type II       

In-situ fundoplication slip

Type III      

Trans-hiatal fundoplication migration

Type IV      

Mixed fundoplication disruption and trans-hiatal fundoplication migration

Type V       

Trans-hiatal fundoplication slip

Type VI      

LINX failure (migration/erosion/persistent dysphagia/poor symptom control)

Indications for surgery

  • troublesome persistent dysphagia following previous anti-reflux/LINX surgery (resistant to non-surgical therapy)

  • patients in whom the primary symptom is volume reflux/regurgitation despite previous anti-reflux/LINX surgery

  • a confirmed diagnosis of recurrent acid reflux after previous anti-reflux/LINX surgery and adequate symptom control with medical therapy but do not wish to continue with long term therapy

  • patient with breakthrough symptoms despite maximum medical therapy for recurrent reflux after previous anti-reflux/LINX surgery

  • a confirmed diagnosis of acid reflux in patients following previous anti-reflux surgery/LINX and symptoms that respond to medical therapy but who are intolerant of medication side effects

  • atypical symptoms such as aspiration, cough or hoarse voice and confirmed evidence of GORD in patients treated previously with anti-reflux/LINX surgery (these patients as a group have less successful outcomes than patients with typical symptoms)

  • LINX explant for erosion/migration

  • LINX explant for psychological reasons

Investigations

  • Previous operative notes

  • OGD endoscopy

  • GI Physiology- ambulatory pH/high resolution manometry

  • Barium swallow

Management 

  • Revisional surgery has more complex management and should be concentrated to a few surgeons within a large unit or a single centre within a region

  • Pass all patients through a hiatal MDT prior to surgery

  • Enter data into a registry to audit outcomes

Key performance Indicators 

  • Mortality < 0.1%

Type I In-Situ Fundoplication Disruption
Type II In-Situ Fundoplication Slip.png
Type III Trans-Hiatal Fundoplication Her
Type IV Mixed Fundoplication Disruption
Type V Fundoplication Slip Herniation.pn
Type VI LINX failure.png

© 2018 by British Benign Upper GastroIntestinal Surgical Society

Follow Us

Follow us on Social Media

  • Twitter
  • LinkedIn

©2018 by British Benign Upper Gastrointestinal Surgical Society. 

bottom of page